banner 1366.jpg
 

An Ounce
of Hope
can make a
Difference

 

WHY IMMUNOTHERAPY?

Immunotherapy is a breakthrough in lung cancer treatment

STRONG

Improves survival among patients with late-stage lung cancer

SPECIFIC

Strengthens the immune system’s capacity to detect and destroy cancer cells

HOPEFUL

More manageable and tolerable side effects compared with other therapies

BIOMARKER TESTING

What is it? How does it work?

AN IMPORTANT FACTOR OF PERSONALIZED MEDICINE

Biomarkers are proteins found in blood, tissues, and fluids that help identify the best possible treatment for a patient.

TARGET FOR IMMUNOTHERAPY

Immunotherapy targets the Programmed Death-Ligand 1 (PD-L1) protein expressed in lung tumors.

ENSURING MAXIMUM BENEFIT

Measuring a patient’s PD-L1 biomarker expression can help ensure the best response to immunotherapy.

4.jpg

THE FUTURE OF CANCER TREATMENT